Biotech

- Advertisement -
Ad imageAd image
Takeda Commits Over $1.7 Billion to AI-Driven Drug Discovery in Major Partnership with Iambic

One of Japan's largest pharmaceutical companies, Takeda Pharmaceutical Company, has ramped up the use of AI in drug research through a multi, year partnership with AI biotech, Iambic Therapeutics, whose…

Quantum Biology: Japan’s Role in the Next Medical Frontier

For many years, Japan has been a world leader in precision, innovation,…

DRC Medicine Ltd to Merge with Ribbon Acquisition Corp.

DRC Medicine Ltd., an innovative healthcare and biotechnology company based in Tokyo,…

AGC Biologics Grows Cell Therapy Presence in Asia

AGC Biologics, your friendly CDMO expert, will commence cell therapy process development…

bitBiome Inc partners with leading CMO for Product Supply

bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes…

Fujirebio Announces Strategic Collaboration with Stanford Medicine

Fujirebio, a leading innovator in in-vitro diagnostics, announced a collaboration with Stanford Medicine…

ConcertAI Adds ASCO® Automation to AI Cancer Tools

ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…

Cellares with Mitsui to Launch Japan’s First IDMO Factory

Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…

Alloy Therapeutics Launches in Japan at Shonan iPark

Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community